DJIA 16,102.38 -272.38 -1.66%
NASDAQ 4,683.92 -49.58 -1.05%
S&P 500 1,921.22 -29.91 -1.53%
market minute promo

company name or ticker
Company Photos
(Click to zoom)

Analysts Break Down Impact Of $7.2B Receptos Buyout

Orexigen- Contrave Sales Dip Despite Market Leadership

Arena Closes Out Quarter On Belviq Sales - How Do The Numbers Look?

Orexigen: Contrave Sales Win The Week, Pace Still Slower Than Needed

Arena - Belviq Sales Slide Again

Vivus- Qsymia Sales Dip And Flatten Out

Novo Nordisk: Anti-Obesity Treatment Saxenda Passes 1,000 Scripts

Obesity Statistics Take a Wrong Turn in This Latest Study

Obesity, the silent killer, costs the global economy $2 trillion annually. Find out what tactics could be used to help curb rising obesity levels.

Arena - Belviq Advertising Report For June

Arena Pharmaceuticals (ARNA): Today's Weak On High Volume Stock

See More Articles...